Squarepoint’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Sell |
24,091
-92,368
| -79% | -$467K | ﹤0.01% | 2455 |
|
|
2025
Q1 | $616K | Buy |
116,459
+36,038
| +45% | +$191K | ﹤0.01% | 1780 |
|
|
2024
Q4 | $544K | Buy |
+80,421
| New | +$544K | ﹤0.01% | 1895 |
|
|
2024
Q2 | – | Sell |
-131,849
| Closed | -$1.31M | – | 2905 |
|
|
2024
Q1 | $1.31M | Buy |
+131,849
| New | +$1.31M | ﹤0.01% | 1210 |
|
|
2023
Q4 | – | Sell |
-161,816
| Closed | -$1.24M | – | 2886 |
|
|
2023
Q3 | $1.24M | Buy |
161,816
+37,842
| +31% | +$289K | ﹤0.01% | 1197 |
|
|
2023
Q2 | $926K | Sell |
123,974
-66,411
| -35% | -$496K | ﹤0.01% | 1293 |
|
|
2023
Q1 | $1.27M | Buy |
190,385
+120,585
| +173% | +$804K | 0.01% | 1042 |
|
|
2022
Q4 | $538K | Buy |
+69,800
| New | +$538K | ﹤0.01% | 1419 |
|
|
2022
Q2 | – | Sell |
-56,332
| Closed | -$403K | – | 2558 |
|
|
2022
Q1 | $403K | Sell |
56,332
-1,125
| -2% | -$8.05K | ﹤0.01% | 1596 |
|
|
2021
Q4 | $984K | Buy |
+57,457
| New | +$984K | ﹤0.01% | 1230 |
|